Overview

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Group A: Long-term follow-up is needed for subjects identified as acute or early in the course of HIV-1 infection, independent of decisions regarding therapy with highly active anti-retroviral therapy (HAART). Group B: This protocol will also be offered to subjects who were diagnosed with acute HIV-1 infection in the past and have been participating in an ADARC/Rockefeller University Hospital treatment protocol for acute HIV-1 infection, and currently have a viral load consistently less than 50 copies/ml on current treatment (Group B)
Details
Lead Sponsor:
Rockefeller University
Collaborator:
Aaron Diamond AIDS Research Center
Treatments:
Anti-Retroviral Agents